KDL Biotech Financials
NSE: KOPDRUGS | BSE: 532291
₹2.14
As on 16-Mar-2015IST
Market cap
₹5 Cr
Revenue (TTM)
₹26 Cr
P/E Ratio
--
P/B Ratio
-0.1
Div. Yield
0 %
Income Statement (₹ Cr) |
TTM | Mar-12 | Mar-11 | Mar-10 | Sep-08 | Sep-07 | Mar-06 | Sep-05 | Mar-04 | Mar-03 | Mar-02 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
--
|
26.47
|
28.41
|
38.38
|
56.84
|
169.54
|
|||||
|
Total Income
|
--
|
27.22
|
28.73
|
40.23
|
62.47
|
190.00
|
|||||
|
Total Expenditure
|
2.12
|
28.53
|
44.76
|
48.50
|
66.32
|
180.34
|
|||||
|
EBITDA
|
-2.12
|
-2.07
|
-16.36
|
-10.12
|
-9.47
|
-10.80
|
|||||
|
Depreciation
|
6.89
|
9.13
|
22.35
|
12.40
|
6.90
|
10.20
|
|||||
|
EBIT
|
-9.01
|
-11.20
|
-38.70
|
-22.52
|
-16.37
|
-21.00
|
|||||
|
Interest
|
5.41
|
6.77
|
6.74
|
2.99
|
10.35
|
12.94
|
|||||
|
Other Income
|
0.22
|
0.76
|
0.32
|
1.86
|
5.63
|
20.46
|
|||||
|
Exceptional Items
|
--
|
--
|
-11.50
|
6.66
|
--
|
--
|
|||||
|
Profit before Tax
|
-14.20
|
-17.21
|
-56.62
|
-16.99
|
-21.09
|
-13.48
|
|||||
|
Provision for Tax
|
--
|
--
|
7.69
|
0.02
|
0.04
|
0.06
|
|||||
|
Profit after Tax
|
-14.20
|
-17.21
|
-64.31
|
-17.01
|
-21.13
|
-13.55
|
Liabilities (₹ Cr) |
TTM | Mar-12 | Mar-11 | Mar-10 | Sep-08 | Sep-07 | Mar-06 | Sep-05 | Mar-04 | Mar-03 | Mar-02 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
-75.38
|
-59.17
|
-41.96
|
22.35
|
39.36
|
-0.27
|
|||||
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Non-Current Liabilities
|
2.84
|
2.66
|
2.23
|
49.68
|
56.56
|
82.86
|
|||||
|
Current Liabilities
|
123.28
|
113.21
|
105.08
|
26.28
|
15.64
|
63.37
|
|||||
|
Total Liabilities
|
50.73
|
56.70
|
65.35
|
106.01
|
119.26
|
145.96
|
Assets (₹ Cr) |
TTM | Mar-12 | Mar-11 | Mar-10 | Sep-08 | Sep-07 | Mar-06 | Sep-05 | Mar-04 | Mar-03 | Mar-02 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
41.98
|
49.80
|
58.58
|
79.17
|
82.85
|
74.61
|
|||||
|
Current Assets
|
7.29
|
6.89
|
6.77
|
19.14
|
28.72
|
71.35
|
|||||
|
Total Assets
|
50.73
|
56.70
|
65.35
|
106.01
|
119.26
|
145.96
|
|||||
|
Total Debt*
|
--
|
60.26
|
60.14
|
57.37
|
64.25
|
82.86
|
|||||
|
Net Current Assets
|
-115.99
|
-106.32
|
-98.32
|
-7.14
|
13.07
|
7.98
|
|||||
|
Contingent Liabilities
|
--
|
90.96
|
92.81
|
13.32
|
3.14
|
--
|
Cashflow (₹ Cr) |
TTM | Mar-12 | Mar-11 | Mar-10 | Sep-08 | Sep-07 | Mar-06 | Sep-05 | Mar-04 | Mar-03 | Mar-02 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
6.79
|
1.57
|
3.25
|
-6.31
|
2.57
|
|||||
|
Cash Flow from Investing Activities
|
--
|
0.00
|
-0.08
|
-0.66
|
-15.03
|
-1.55
|
|||||
|
Cash from Financing Activities
|
--
|
-6.73
|
-1.79
|
-3.21
|
22.38
|
-1.60
|
|||||
|
Net Cash Inflow / Outflow
|
--
|
0.06
|
-0.30
|
-0.62
|
1.03
|
-0.58
|
Financials Ratios |
TTM | Mar-12 | Mar-11 | Mar-10 | Sep-08 | Sep-07 | Mar-06 | Sep-05 | Mar-04 | Mar-03 | Mar-02 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
-5.91
|
-7.16
|
-26.76
|
-7.08
|
-8.79
|
-8.08
|
|||||
|
Cash EPS (₹)
|
--
|
-3.36
|
-17.46
|
-1.92
|
-5.92
|
-2.00
|
|||||
|
Adjusted Book Value (₹)
|
--
|
-24.62
|
-17.46
|
9.30
|
16.38
|
-0.16
|
|||||
|
Dividend per Share (₹)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash Flow per Share (₹)
|
--
|
2.82
|
0.65
|
1.35
|
-2.63
|
1.53
|
|||||
|
Free Cash Flow per Share (₹)
|
--
|
0.18
|
-15.77
|
1.84
|
-16.42
|
5.79
|
Profitability Ratios |
TTM | Mar-12 | Mar-11 | Mar-10 | Sep-08 | Sep-07 | Mar-06 | Sep-05 | Mar-04 | Mar-03 | Mar-02 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
-108.39
|
-101.90
|
-15.27
|
-11.54
|
-0.57
|
|||||
|
ROE (%)
|
--
|
--
|
--
|
-55.12
|
-108.11
|
--
|
|||||
|
ROA (%)
|
-26.44
|
-28.21
|
-78.59
|
-16.21
|
-16.41
|
-9.49
|
|||||
|
EBIT Margin (%)
|
--
|
-42.32
|
-136.25
|
-58.68
|
-28.80
|
-12.39
|
|||||
|
Net Margin (%)
|
-6,396.85
|
-63.22
|
-223.86
|
-42.27
|
-33.83
|
-7.13
|
|||||
|
Cash Profit Margin (%)
|
--
|
-29.64
|
-144.55
|
-11.63
|
-23.65
|
-1.87
|
Growth Ratios |
TTM | Mar-12 | Mar-11 | Mar-10 | Sep-08 | Sep-07 | Mar-06 | Sep-05 | Mar-04 | Mar-03 | Mar-02 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
--
|
-6.83
|
-25.98
|
-32.49
|
-66.47
|
206.93
|
|||||
|
EBIT Growth (%)
|
5.99
|
71.06
|
-71.88
|
--
|
22.04
|
--
|
|||||
|
Net Profit Growth (%)
|
11.98
|
73.24
|
-278.13
|
19.51
|
-55.97
|
-20.11
|
|||||
|
EPS Growth (%)
|
--
|
73.24
|
-278.13
|
19.51
|
-8.78
|
-20.11
|
|||||
|
Book Value Growth (%)
|
--
|
-41.02
|
-287.73
|
-43.21
|
14,768.59
|
-209.47
|
Valuation Ratios |
TTM | Mar-12 | Mar-11 | Mar-10 | Sep-08 | Sep-07 | Mar-06 | Sep-05 | Mar-04 | Mar-03 | Mar-02 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Price / Book Value
|
-0.05
|
-0.15
|
-0.31
|
1.33
|
0.71
|
-89.64
|
|||||
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EV/EBITDA
|
-34.23
|
-52.39
|
-4.53
|
-10.46
|
-23.64
|
11.04
|
|||||
|
Close Price (₹)
|
1.62
|
4.00
|
5.35
|
12.15
|
11.65
|
14.55
|
|||||
|
High Price (₹)
|
4.00
|
9.25
|
16.35
|
17.30
|
28.80
|
20.50
|
|||||
|
Low Price (₹)
|
1.62
|
3.29
|
5.00
|
3.95
|
7.55
|
10.15
|
|||||
|
Market Cap (₹ Cr)
|
5.14
|
8.80
|
12.95
|
29.80
|
28.00
|
24.05
|
Solvency Ratios |
TTM | Mar-12 | Mar-11 | Mar-10 | Sep-08 | Sep-07 | Mar-06 | Sep-05 | Mar-04 | Mar-03 | Mar-02 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
0.00
|
-1.02
|
-1.43
|
2.57
|
1.63
|
-308.82
|
|||||
|
Short term debt to equity ratio
|
-1.63
|
-0.87
|
-1.22
|
--
|
--
|
--
|
|||||
|
Current Ratio
|
0.06
|
0.06
|
0.06
|
0.73
|
1.84
|
1.13
|
|||||
|
Quick Ratio
|
0.04
|
0.04
|
0.04
|
0.60
|
1.50
|
0.66
|
|||||
|
Interest Coverage
|
-1.62
|
-1.54
|
-7.40
|
-4.69
|
-1.04
|
-0.04
|
Operating Efficiency Ratios |
TTM | Mar-12 | Mar-11 | Mar-10 | Sep-08 | Sep-07 | Mar-06 | Sep-05 | Mar-04 | Mar-03 | Mar-02 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
--
|
0.06
|
1.04
|
0.18
|
1.83
|
13.32
|
|||||
|
Asset Turnover
|
--
|
0.45
|
0.35
|
0.38
|
0.47
|
1.26
|
|||||
|
Receivable days
|
--
|
2.08
|
2.29
|
5.11
|
71.62
|
55.32
|
|||||
|
Inventory Days
|
--
|
34.92
|
38.80
|
39.94
|
105.73
|
44.67
|
|||||
|
Payable days
|
--
|
425.93
|
647.98
|
354.16
|
343.20
|
98.86
|
|||||
|
Cash Conversion Cycle
|
--
|
-388.93
|
-606.89
|
-309.11
|
-165.84
|
1.12
|